MATERIALS AND METHODS
This study includes 25 204 women born between 1925 and 1965 who participated in the Nord-Trøndelag Health Survey between 1984 and 1986 (Holmen and Midthjell, 1990 . All residents in Nord-Trøndelag country aged 20 years or older were invited to participate in a brief health examination that included anthropometric measurements and self-administered questionnaires that provided information on medical history and lifestyle factors.
The participants were followed from the date of entry to the study (between January 1984 to April 1986) until the date of cancer diagnosis (of all sites), death, emigration, or the cut-off date of 1 January 1996, whichever occurred first. The unique identification number of every citizen in Norway enabled linkage to the national Cancer Registry in order to identify incident cases of cancer. To achieve a high degree of completeness and data quality, the material of the Cancer Registry is matched against the Register of Deaths at Statistics Norway. For all cancer cases registered since 1953, 84.7% are histologically verified and only 1.7% of the diagnoses are based on death certificate alone (Cancer Registry of Norway, 1998).
We used the Cox proportional hazards model (Kleinbaum, 1995) to compute incidence rate ratios (RRs) of breast cancer associated with adult height by year of birth. Height was categorized into tertiles according to the distribution of the total population (cut-off = 162 cm and 167 cm), while year of birth was categorized into five birth cohorts. (< 30, 30-34, and ≥ 35 years) . Further multivariate analyses were conducted to assess potential confounding by body mass index (BMI), smoking, and physical activity. All statistical analyses were performed using the statistical software SPSS for Windows (Release 10.0.5, Copyright © SPSS Inc., 1989 -1999 .
RESULTS
During almost 12 years of follow-up (median = 11.0 years) we observed a total of 276 239 person-years, and 215 incident cases of breast cancer were registered. Mean age at study entry was 39.5 years (range = 20-61 years) and mean age at diagnosis of breast cancer was 53.4 years (range = 31-70 years).
We found no independent effect of height on the risk of breast cancer in the total population (age-adjusted P-trend = 0.6). However, in analyses stratified by birth cohort we found a strong positive association with height among the 3792 women (43 cases) who where born during World War II, where women in the tallest tertile of height (> 167 cm) had more than twice the risk of breast cancer compared with women in the shortest tertile (≤ 162 cm) (RR = 2.5; 95% CI = 1.2-5.5) ( Table 1) . For women in the other birth cohorts there was no significant association between height and breast cancer risk. Adjustment for BMI, smoking and physical activity did not change these results (data not shown).
DISCUSSION
In this prospective study of Norwegian women, we found that an association between adult height and breast cancer risk was confined to women who were born during World War II. Women in the highest tertile of height had more than twice the risk of breast cancer compared with women in the lowest tertile. Among women born before or after the war we found no clear association with height.
We adjusted for differences in body mass index, smoking, and physical activity. However, we had no information on age at menarche, age at first full-term pregnancy, and parity, and this may be a weakness of our study. Also, by stratifying cases according to birth cohorts, the number of cases within each category of height was small, thereby reducing the precision of the results.
Recently, the association between indicators of birth size and breast cancer risk has received attention, and some studies have reported a positive association with birth weight (Ekbom et al, 1992; Michels et al, 1996; Sanderson et al, 1996; Stavola et al, 2000; Kaijser et al, 2001 ). Others, however, have not been able to confirm this finding (Ekbom et al, 1997; Le Marchand et al, 1988) . For birth length or placenta weight, there have been no clear findings, but preeclampsia in the mother, which is associated with reduced fetal growth, appears to reduce the risk of breast cancer in the daughters (Ekbom et al, 1992; Ekbom et al, 1997; Sanderson et al, 1998) .
In a previous Norwegian cohort study, there was a positive association between height and breast cancer risk among women whose peripubertal growth coincided with World War II (Vatten and Kvinnsland, 1990) . Also, a large ecological study in Norway found that the incidence of breast cancer was lower than expected among women who experienced puberty during the war (Tretli and Gaard, 1996) . In the present cohort we found no significant association with height among women who were born in the late 1920s or early 1930s, as would be predicted from the other two Norwegian studies. The cancer cases contributing to the effect of WWII in the present study and in the study by Vatten and Kvinnsland were mainly pre-menopausal. Tretli (1989) found, however, that the association between height and breast cancer did not substantially differ by age at diagnosis.
If fetal or childhood growth is important for a girl's prospects of developing breast cancer, one important set of biological mediators may be the insulin-like growth factors (IGFs) (Smith et al, 2000) . The IGFs play an important role during the peripubertal growth spurt, and tallness is positively associated with plasma IGF-I levels (Juul et al, 1994) . It is, however, unclear whether differences in IGF levels during early development are reflected in differences in adult IGF. Recently, two prospective studies of IGF-I measured in adult women found a positive association with risk of premenopausal, but not postmenopausal breast cancer (Hankinson et al, 1998; Toniolo et al, 2000) .
In summary, this study shows a strong positive association between adult height and risk of breast cancer among the women Galtung-Hansen, 1947; Strøm, 1948) and a deceleration in the secular height gain observed before the war (Brundtland et al, 1980) . We suggest that the strong association with height may reflect greater nutritional diversity during gestation among the mothers, implying a role for early nutrition in the aetiology of breast cancer.
